Stock Analiz

Century Therapeutics, Inc. (IPSC) stock forecast and price target

Price $1.65 · data as of November 13, 2026

12-month price target

Average target$4.75
Upside / downside+187.9%
Analysts4
ConsensusBuy
Low $2.00Average $4.75High $8.00

Gold marker: average target · white marker: today’s price ($1.65)

Analyst ratings

Strong buy 1Buy 3Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.52−1471.0%$0
Next fiscal year
ends December 31, 2027
$-0.45+14.4%$0
Next quarter
ends December 31, 2026
$-0.12+54.0%$0
Quarter after
ends March 31, 2027
$-0.12−9.1%$0

Consensus of the analysts covering Century Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Century Therapeutics stock price target?

The average 12-month target from 4 analysts is $4.75, 187.9% above the current price of $1.65 Targets range from $2.00 to $8.00.

Is Century Therapeutics a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 3 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Century Therapeutics expected to earn?

Analysts expect EPS of $-0.52 for the fiscal year ending December 31, 2026 and $-0.45 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.